Biodesix annual r&d spending
2019
2020
2021
2022
2023
2024
2025
Biodesix R&D Spending Growth & History (BDSX)
Biodesix's r&d spending was $12.0M for fiscal 2025.
View full Biodesix company overviewBiodesix annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $12.0M | $2.4M | +25.55% |
| 2024 | 2024-12-31 | $9.6M | −$429,000 | −4.30% |
| 2023 | 2023-12-31 | $10.0M | −$3.1M | −23.77% |
| 2022 | 2022-12-31 | $13.1M | $313,000 | +2.45% |
| 2021 | 2021-12-31 | $12.8M | $2.0M | +18.22% |
| 2020 | 2020-12-31 | $10.8M | $350,000 | +3.34% |
| 2019 | 2019-12-31 | $10.5M | — | — |
Biodesix quarterly r&d spending
Q3.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.1M | −$134,000 | −4.10% |
| Q1 2026 | 2026-03-31 | $3.3M | $415,000 | +14.46% |
| Q4 2025 | 2025-12-31 | $2.9M | $456,000 | +18.89% |
| Q3 2025 | 2025-09-30 | $3.0M | $445,000 | +17.47% |
| Q2 2025 | 2025-06-30 | $3.3M | $711,000 | +27.80% |
| Q1 2025 | 2025-03-31 | $2.9M | $830,000 | +40.69% |
| Q4 2024 | 2024-12-31 | $2.4M | $525,000 | +27.79% |
| Q3 2024 | 2024-09-30 | $2.5M | $609,000 | +31.42% |
| Q2 2024 | 2024-06-30 | $2.6M | −$352,000 | −12.10% |
| Q1 2024 | 2024-03-31 | $2.0M | −$1.2M | −37.25% |
| Q4 2023 | 2023-12-31 | $1.9M | −$1.7M | −47.01% |
| Q3 2023 | 2023-09-30 | $1.9M | −$1.0M | −34.75% |
| Q2 2023 | 2023-06-30 | $2.9M | −$451,000 | −13.42% |
| Q1 2023 | 2023-03-31 | $3.3M | $45,000 | +1.40% |
| Q4 2022 | 2022-12-31 | $3.6M | $713,000 | +25.00% |
| Q3 2022 | 2022-09-30 | $3.0M | −$323,000 | −9.81% |
| Q2 2022 | 2022-06-30 | $3.4M | $38,000 | +1.14% |
| Q1 2022 | 2022-03-31 | $3.2M | −$115,000 | −3.46% |
| Q4 2021 | 2021-12-31 | $2.9M | −$253,000 | −8.15% |
| Q3 2021 | 2021-09-30 | $3.3M | $587,000 | +21.69% |
| Q2 2021 | 2021-06-30 | $3.3M | $1.2M | +57.71% |
| Q1 2021 | 2021-03-31 | $3.3M | $421,000 | +14.52% |
| Q4 2020 | 2020-12-31 | $3.1M | — | — |
| Q3 2020 | 2020-09-30 | $2.7M | $347,000 | +14.71% |
| Q2 2020 | 2020-06-30 | $2.1M | — | — |
| Q1 2020 | 2020-03-31 | $2.9M | — | — |
| Q3 2019 | 2019-09-30 | $2.4M | — | — |
Biodesix r&d spending trends
Over the last five fiscal years, Biodesix's r&d spending increased from $10.8M to $12.0M, a change of $1.2M. The latest reported quarter, Q2 2026, shows $3.1M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biodesix source filings ↗